Susquehanna Fundamental Investments, LLC Onconova Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.95 - $1.45 $36,353 - $55,487	-38,267 Reduced 53.03%	33,900 $30,000
Q4 2021 Feb 14, 2022	BUY	$2.49 - $3.73 $115,379 - $172,837	46,337 Added 179.39%	72,167 $184,000
Q3 2021 Nov 15, 2021	BUY	$3.81 - $6.76 $3,429 - $6,084	900 Added 3.61%	25,830 $99,000
Q2 2021 Aug 11, 2021	BUY	$6.28 - $16.2 $156,560 - $403,866	24,930 New	24,930 $173,000

276K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.